Biotechnology

Sterne Kessler is a pioneer in the protection and enforcement of biotechnology IP, including biopharmaceuticals, industrial biotechnology, and biosimilars.

Sterne Kessler's biotechnology practice was established just as the biotech revolution was beginning. Today, our practice is as diverse as the industry itself. We counsel clients worldwide on IP strategy across major applications of biotechnology—medicine and healthcare, agricultural processes, non-food and industrial processes, and environmental uses. Clients trust Sterne Kessler throughout the product lifecycle to help them navigate the opportunities and challenges unique to the industry. Biopharmaceuticals Sterne Kessler's biopharmaceuticals team works with biologic drug companies to develop, enforce, and defend patent portfolios. Biosimilars We help companies navigate the substantial opportunities and challenges associated with the launch of new biosimilar drugs. Therapeutic Antibodies We carefully manage intellectual property (IP) issues for therapeutic antibody innovators, ensuring they navigate development hurdles and achieve ambitious financial objectives. Industrial & Agricultural Biotech Sterne Kessler has developed landmark patents and won seminar disputes in the industrial and agricultural biotechnology industry.

Leadership

Related News & Insights

Webinar Recordings & Materials

January 19, 2023

2022 Trademark Year in Review: Analysis and Trends – Recording

Webinar

January 10, 2023 9:30 AM - 11:30 AM PST

Unified Patent Court (UPC) and ADR

Speaking Engagement

January 9, 2023 8:45 AM - 10:00 AM PST

Guidelines for the Efficient Resolution of Disputes before the Forthcoming Unified Patent Court